Background: A major cause of death in dogs with immune‐mediated hemolytic anemia
(IMHA) is thromboembolism. Previous studies suggest unfractionated heparin (UH) is not …

Cytokine abnormalities have been described previously in dogs with varied immune
mediated and inflammatory conditions such as IMHA and sepsis. The purpose of this study …

Background Immune-mediated haemolytic anaemia (IMHA) has a high mortality rate within
the first weeks to months of diagnosis. Identifying dogs at increased risk of death may help …

Objective Evaluate the survival and prognostic indicators (ie breed predilection, season,
blood transfusion, and the prevalence of autoagglutination) of dogs with immune‐mediated …

Objective—To describe the effects of prednisone and acetylsalicylic acid (ASA) on results of
thromboelastography in healthy dogs. Animals—16 male mixed-breed dogs. Procedures …

The utility of thoracic radiographs and abdominal ultrasound to identify abnormalities in
canine immune-mediated hemolytic anemia (IMHA) is evaluated. Dogs with regenerative …

Objective–To investigate the clinical application and potential utility of plasmapheresis in
canine immune‐mediated hemolytic anemia. Case Summary–A 7‐year‐old spayed female …

Cyclosporine and aspirin are routinely used in combination to treat immune-mediated
hemolytic anemia (IMHA) in dogs. Cyclosporine is a potent immunosuppressive agent that …

Objective–To identify and characterize the syndrome of immune‐mediated hemolytic
anemia (IMHA) with concurrent severe thrombocytopenia (≤ 15.0× 109 platelets/L;[15.0× …

Objectives: The assessment of serum cardiac troponin I concentrations in dogs with a range
of nonprimary cardiac illnesses has revealed that cardiac myocyte damage is commonplace …